Hualan Biological Vaccine, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -46.85% vs 2,074.93% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -54.62% vs 1,029.17% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "396.50",
          "val2": "746.00",
          "chgp": "-46.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "64.00",
          "val2": "139.00",
          "chgp": "-53.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.40",
          "val2": "4.80",
          "chgp": "-150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "50.60",
          "val2": "111.50",
          "chgp": "-54.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.30%",
          "val2": "138.90%",
          "chgp": "-6.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.68% vs -53.23% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -11.00% vs -76.10% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,198.10",
          "val2": "1,123.10",
          "chgp": "6.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "231.50",
          "val2": "236.70",
          "chgp": "-2.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "6.20",
          "chgp": "-58.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "12.70",
          "val2": "24.30",
          "chgp": "-47.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "182.90",
          "val2": "205.50",
          "chgp": "-11.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "75.40%",
          "val2": "84.30%",
          "chgp": "-0.89%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

396.50

746.00

-46.85%

Operating Profit (PBDIT) excl Other Income

64.00

139.00

-53.96%

Interest

0.00

0.00

Exceptional Items

-2.40

4.80

-150.00%

Consolidate Net Profit

50.60

111.50

-54.62%

Operating Profit Margin (Excl OI)

72.30%

138.90%

-6.66%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -46.85% vs 2,074.93% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -54.62% vs 1,029.17% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,198.10

1,123.10

6.68%

Operating Profit (PBDIT) excl Other Income

231.50

236.70

-2.20%

Interest

2.60

6.20

-58.06%

Exceptional Items

12.70

24.30

-47.74%

Consolidate Net Profit

182.90

205.50

-11.00%

Operating Profit Margin (Excl OI)

75.40%

84.30%

-0.89%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 6.68% vs -53.23% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -11.00% vs -76.10% in Dec 2024

All Annual Results